Showing results (31-40 of 82) with videos related to

Sort By:
Pageof 9
Clinical and Translational Radiation Oncology|March 22, 2021
Phase I trial of the MEK inhibitor selumetinib in combination with thoracic radiotherapy in non-small cell lung cancerK Haslett, P Koh, A Hudson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1995
Doxifluridine and leucovorin: an oral treatment combination in advanced colorectal cancerE Bajetta, M Colleoni, M Di Bartolomeo, et al.
British Journal of Cancer|January 8, 2004
Efficacy and tolerability of gefitinib in pretreated elderly patients with advanced non-small-cell lung cancer (NSCLC)F Cappuzzo, S Bartolini, G L Ceresoli, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 29, 2008
Optimisation of circulating biomarkers of cell death for routine clinical useA Greystoke, J Cummings, T Ward, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 10, 2011
Correlation of cytidine deaminase polymorphisms and activity with clinical outcome in gemcitabine-/platinum-treated advanced non-small-cell lung cancer patientsC Tibaldi, E Giovannetti, M Tiseo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 15, 2010
Consequences of targeted treatments for second-line therapyE De Maio, C Tibaldi, A D'Incecco, et al.
Journal of Clinical Pathology|October 29, 2009
EGFR fluorescence in situ hybridisation assay: guidelines for application to non-small-cell lung cancerM Varella-Garcia, J Diebold, D A Eberhard, et al.
British Journal of Cancer|December 22, 2011
A pilot study to explore circulating tumour cells in pancreatic cancer as a novel biomarkerL Khoja, A Backen, R Sloane, et al.
Pageof 9